3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
47
Breast Neoplasms
9
Salivary Gland Neoplasms
2
Prostate Adenocarcinoma
2
Neoplasm Metastasis
2
Breast Neoplasms, Male
2
Stage I Prostate Adenocarcinoma AJCC v7
1
Sexual Dysfunctions, Psychological
1
Salivary Gland Neoplasm Duct
1
Primary Dysautonomias
1
Patient Compliance
1
PSA Level Greater Than Two
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Leukemia
1
Kidney Diseases
1
Hypertension
1
Hormone Sensitive Prostate Cancer
1
Hereditary Sensory and Autonomic Neuropathies
1
HER2-positive Breast Cancer
1
Granulosa cell tumor of the ovary
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma
1
Interventions
olaparib
1
gallium 68 PSMA-11
1
Pluvicto
1
Gemcitabine
1
Cisplatin
1
Androgen Antagonists
1
Adrenal Cortex Hormones
1
Abiraterone Acetate
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
(225)Ac-PSMA-617
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Genital Neoplasms, Male
×
Leuprolide
×
1 year
×
Clear all
No trials found.